Followers | 0 |
Posts | 199 |
Boards Moderated | 0 |
Alias Born | 01/07/2005 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, July 25, 2005 2:41:00 PM
I believe that you are referencing the upgrade of the Beckman Coulter GenomeLab. From data points from Tony and Money’s report of Trace, DNAG is reportedly flooded with work. The upgrade obviously cost money but I do believe that this could be a good purchase if the aforementioned data points continue to hold true. This is not a question of veracity but a question of sustained work. With sustained and incremental increases in work the breakeven moves up on the cost benefit analysis that DNAG hopefully did prior to the purchase and your efficiencies will really materialize. Contrary, if the work in is not sustained than you have a great & fast machine but all day to run the job(s)….the machine would sit idol most of the day.
I hope that you are right and there is a major bottleneck.
Big Blue
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM